United States Wound Care Market Poised for Expansion Driven by Rising Chronic Wound Cases and Technological Innovations

The global wound care market, valued at US$20.97 billion in 2024, is projected to reach US$30.48 billion by 2030, growing at a CAGR of 6.5% during the forecast period (2025–2030). The United States wound care market, as part of this global landscape, is expected to play a pivotal role in shaping industry trends, driven by the country’s advanced healthcare infrastructure, strong presence of key market players, and a growing emphasis on effective treatment for chronic and acute wounds.

Download PDF Brochure of Wound Care Market

The rising number of traumatic injuries, including road and workplace accidents, has led to increased demand for advanced wound care products. According to the World Health Organization, approximately 1.3 million people die annually due to road traffic accidents, while 20 to 50 million suffer non-fatal injuries. Many of these cases require sophisticated wound management to prevent infection, reduce scarring, and accelerate healing. Furthermore, the aging population in the United States and the increasing prevalence of chronic conditions such as diabetes and vascular diseases have contributed significantly to the rising incidence of chronic wounds such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Market Dynamics

Driver: Increasing Incidence of Traumatic and Chronic Wounds

The wound care market in the United States is primarily driven by the growing burden of traumatic injuries and chronic conditions. Industrial accidents, burns, and post-surgical complications have created a steady demand for both advanced and traditional wound care products. The Centers for Disease Control and Prevention (CDC) reports that chronic wounds affect nearly 6.5 million Americans each year, accounting for billions in healthcare spending.

To combat the clinical and economic burden, hospitals and outpatient clinics are increasingly incorporating advanced wound care products such as hydrocolloid dressings, foam dressings, and antimicrobial products into their treatment protocols. The need for faster recovery and reduced hospital stays has further propelled the adoption of next-generation wound care technologies.

Restraint: High Cost of Advanced Wound Care Solutions

While advanced wound care technologies provide superior healing outcomes, their high cost remains a significant barrier to widespread adoption, especially in low-income and uninsured populations. Bioengineered skin substitutes, negative pressure wound therapy (NPWT) systems, and enzymatic debridement products often entail high operational and maintenance costs. Studies have shown that managing chronic non-healing wounds can cost healthcare systems up to US$50 million annually.

Moreover, recurring expenses for dressings, follow-up visits, and the need for sterile environments limit affordability for many patients. This has prompted healthcare providers and policymakers to explore reimbursement policies, value-based care models, and public-private collaborations to ensure equitable access to effective wound care solutions.

Opportunity: Technological Advancements and Smart Wound Care

The integration of digital health technologies in wound management has opened new frontiers for patient care. Smart wound dressings embedded with sensors are now capable of monitoring infection, moisture levels, and healing progress in real-time, transmitting data to clinicians for personalized treatment. Portable negative pressure wound therapy devices have also enhanced mobility and comfort for patients, particularly in home care settings.

These advancements are expected to reduce healing time and hospital readmissions while supporting healthcare systems in optimizing resources. The growing focus on biologics, tissue-engineered products, and regenerative medicine is further expanding treatment options. The adoption of artificial intelligence (AI) for wound assessment and predictive analytics is also expected to revolutionize decision-making in clinical settings, offering scalable and cost-efficient wound care management across the country.

Challenge: Shortage of Trained Wound Care Professionals

Despite technological progress, the shortage of specialized wound care professionals remains a major challenge. Proper wound management requires specialized training in assessment, dressing selection, and infection control. In many healthcare systems, general physicians and nurses lack formal training in wound management protocols, leading to inconsistent treatment outcomes.

To address this, hospitals and medical institutions are launching dedicated wound care training programs and certifications. Expanding the skilled workforce is critical to ensure effective adoption of advanced wound care solutions and to meet the growing demand in hospitals, long-term care facilities, and home healthcare environments.

Market Segmentation

By Product

The advanced wound care segment commanded the largest share of the market in 2024. This category includes advanced wound dressings (foam, hydrocolloid, film, alginate, and hydrogel dressings), negative pressure wound therapy systems, and biological skin substitutes. These products offer improved moisture balance, infection prevention, and faster healing, making them a preferred choice among healthcare professionals.

The growing awareness of hospital-acquired infections (HAIs) has accelerated the demand for antimicrobial dressings and smart dressings. Manufacturers are also focusing on combining biological materials and nanotechnology to create next-generation wound care products that enhance patient comfort and healing efficiency.

By Wound Type

The market is divided into chronic and acute wounds, with chronic wounds—such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers—accounting for the largest share in 2024. This segment’s dominance can be attributed to the increasing prevalence of diabetes and obesity, particularly in aging populations. Chronic wounds require continuous care and monitoring, making them a key driver of revenue in the United States wound care market.

By End User

Hospitals and clinics held the largest market share in 2024, driven by the availability of advanced wound management infrastructure and skilled medical staff. Within this category, inpatient and outpatient care settings both contribute significantly to market revenues. Home care settings and long-term care facilities are also witnessing rising demand, fueled by the expansion of remote monitoring technologies and patient-centric treatment approaches.

Regional Outlook

In North America, the wound care market is expected to witness steady growth over the forecast period, with the United States leading due to its robust healthcare ecosystem and early adoption of advanced wound care technologies. The expanding geriatric population, rising prevalence of diabetes, and frequent surgical procedures are major contributors to market growth. Furthermore, government initiatives promoting healthcare accessibility and reimbursement for advanced wound care therapies are strengthening the market landscape.

Canada is also emerging as a strong regional contributor, supported by increasing awareness campaigns and a focus on improving chronic wound management practices. The combined efforts of both nations are shaping North America as a global hub for wound care innovation and clinical excellence.

Key Players

Prominent players shaping the United States wound care market include:

Solventum (US), Johnson & Johnson Services, Inc. (US), Cardinal Health (US), Organogenesis Inc. (US), MIMEDX Group, Inc. (US), Medline Industries, LP (US), Owens & Minor (US), Zimmer Biomet (US), Bioventus (US), Baxter (US), and DeRoyal Industries, Inc. (US).

Other global players influencing the market landscape include Smith+Nephew (UK), Mölnlycke AB (Sweden), Convatec Group PLC (UK), Coloplast Group (Denmark), PAUL HARTMANN AG (Germany), and Essity Aktlebolag (Sweden).

These companies are actively investing in research and development, strategic partnerships, and product innovation to strengthen their market presence and deliver value-driven wound care solutions.

Conclusion

The United States wound care market stands at the forefront of medical innovation, characterized by technological advancements, expanding applications of biologics, and increasing focus on patient-centric care. With a rising burden of chronic wounds and growing emphasis on effective and affordable wound management, the market is set for sustained growth through 2030. As healthcare systems continue to evolve, collaboration between manufacturers, healthcare providers, and policymakers will play a critical role in improving wound care accessibility, affordability, and outcomes across the nation.